Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists

Journal of Infectious Diseases

Volumn 186, Issue 4, 2002, Pages 511-516

  Delima, Andrew J ^a   Karatzas, Spyros ^a   Amar, Salomon ^a   Graves, Dana T ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; MACACA; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; TISSUE NECROSIS;

ALVEOLAR BONE LOSS; ANIMALS; BACTEROIDACEAE INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INTERLEUKIN-1; MACACA FASCICULARIS; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; TREATMENT OUTCOME;

EID: 0037103536     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/341778     Document Type: Article

References (36)

1. Periodontal diseases in the US in 1981: Prevalence, severity, extent, and role in tooth mortality
2. Periodontal disease
3. Role of matrix metalloproteinases in human periodontal diseases
4. Biologic basis for interleukin-1 in disease
5. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types
6. IL-1 receptor accessory protein is an essential component of the IL-1 receptor
7. The type II "decoy" receptor: A novel regulatory pathway for interleukin-1
8. Induction of intracellular interleukin-1 beta signals via type II interleukin-1 receptor in human gingival fibroblasts
9. Potential role of interleukin-1 allergen-induced late asthmatic reactions in guinea pigs: Suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction
10. Pathophysiological role of cytokines in congestive heart failure
11. Anti-interleukin-1 therapy in rheumatic diseases
12. Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor
13. Pre-term labor: An intra-uterine inflammatory response syndrome?
14. Functional role of interleukin 1 in periodontal disease: Induction of interleukin 1 production by Bacteroides gingivalis lipopolysaccharide in peritoneal macrophages from C3H/HeN and S3H/Hej mice
15. Cytokine responses of oral epithelial cells to Porphyromonas gingivalis infection
16. Localization of interleukin-1 beta in human periodontal tissue
17. Cytokine profiles of cells extracted from humans with periodontal diseases
18. The interleukin-1 genotype as a severity factor in adult periodontal disease
19. Polymorphisms of the interleukin-1 gene family, oral microbial pathogens, and smoking in adult periodontitis
20. IL-1 genotype and adult periodontitis among young New Zealanders
21. Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor
22. Non-human primates used in studies of periodontal disease pathogenesis: A review of the literature
23. Implantation of Bacteroides gingivalis in non-human primates initiates progression of periodontitis
24. Interleukin-1 and tumor necrosis factor antagonists inhibit the progression of inflammatory cell infiltration toward alveolar bone in experimental periodontitis
25. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis
26. Flurbiprofen: A potent inhibitor of alveolar bone resorption in beagles
27. A chemically modified non-antimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats
28. Activation of neutrophils by interleukins-1 and -2 and tumor necrosis factors
29. Interleukin-1 receptor signaling rather than that of tumor necrosis factor is critical in protecting the host from the severe consequences of a polymicrobe anaerobic infection
30. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat
31. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia
32. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis
33. Changes in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta
34. Periodontal pathogens stimulate CC-chemokine production by mononuclear and bone derived cells
35. Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection
36. Therapeutic approaches to bone diseases